138 related articles for article (PubMed ID: 14506720)
21. Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms.
Pilop C; Aregger F; Gorman RC; Brunisholz R; Gerrits B; Schaffner T; Gorman JH; Matyas G; Carrel T; Frey BM
Circulation; 2009 Sep; 120(11):983-91. PubMed ID: 19720936
[TBL] [Abstract][Full Text] [Related]
22. Interaction of filamin A with the integrin beta 7 cytoplasmic domain: role of alternative splicing and phosphorylation.
Travis MA; van der Flier A; Kammerer RA; Mould AP; Sonnenberg A; Humphries MJ
FEBS Lett; 2004 Jul; 569(1-3):185-90. PubMed ID: 15225631
[TBL] [Abstract][Full Text] [Related]
23. Limited proteolysis of filamin is catalyzed by caspase-3 in U937 and Jurkat cells.
Umeda T; Kouchi Z; Kawahara H; Tomioka S; Sasagawa N; Maeda T; Sorimachi H; Ishiura S; Suzuki K
J Biochem; 2001 Oct; 130(4):535-42. PubMed ID: 11574073
[TBL] [Abstract][Full Text] [Related]
24. Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.
Dalkilic I; Schienda J; Thompson TG; Kunkel LM
Mol Cell Biol; 2006 Sep; 26(17):6522-34. PubMed ID: 16914736
[TBL] [Abstract][Full Text] [Related]
25. A new member of the LIM protein family binds to filamin B and localizes at stress fibers.
Takafuta T; Saeki M; Fujimoto TT; Fujimura K; Shapiro SS
J Biol Chem; 2003 Apr; 278(14):12175-81. PubMed ID: 12496242
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Z-band associated protein complex involving KY, FLNC and IGFN1.
Baker J; Riley G; Romero MR; Haynes AR; Hilton H; Simon M; Hancock J; Tateossian H; Ripoll VM; Blanco G
Exp Cell Res; 2010 Jul; 316(11):1856-70. PubMed ID: 20206623
[TBL] [Abstract][Full Text] [Related]
27. Filamin C-related myopathies: pathology and mechanisms.
Fürst DO; Goldfarb LG; Kley RA; Vorgerd M; Olivé M; van der Ven PF
Acta Neuropathol; 2013 Jan; 125(1):33-46. PubMed ID: 23109048
[TBL] [Abstract][Full Text] [Related]
28. DNA sequencing errors in molecular diagnostics of filamin myopathy.
Odgerel Z; van der Ven PF; Fürst DO; Goldfarb LG
Clin Chem Lab Med; 2010 Oct; 48(10):1409-14. PubMed ID: 20578970
[TBL] [Abstract][Full Text] [Related]
29. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
[TBL] [Abstract][Full Text] [Related]
30. HSPB7 interacts with dimerized FLNC and its absence results in progressive myopathy in skeletal muscles.
Juo LY; Liao WC; Shih YL; Yang BY; Liu AB; Yan YT
J Cell Sci; 2016 Apr; 129(8):1661-70. PubMed ID: 26929074
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the filamin N-terminal region reveals a hinge between the actin binding and first repeat domains.
Sawyer GM; Sutherland-Smith AJ
J Mol Biol; 2012 Dec; 424(5):240-7. PubMed ID: 23036857
[TBL] [Abstract][Full Text] [Related]
32. The limits of promiscuity: isoform-specific dimerization of filamins.
Himmel M; Van Der Ven PF; Stöcklein W; Fürst DO
Biochemistry; 2003 Jan; 42(2):430-9. PubMed ID: 12525170
[TBL] [Abstract][Full Text] [Related]
33. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
[TBL] [Abstract][Full Text] [Related]
34. The C-terminal rod 2 fragment of filamin A forms a compact structure that can be extended.
Ruskamo S; Gilbert R; Hofmann G; Jiang P; Campbell ID; Ylänne J; Pentikäinen U
Biochem J; 2012 Sep; 446(2):261-9. PubMed ID: 22676060
[TBL] [Abstract][Full Text] [Related]
35. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
36. Involvement of filamin A and filamin A-interacting protein (FILIP) in controlling the start and cell shape of radially migrating cortical neurons.
Sato M; Nagano T
Anat Sci Int; 2005 Mar; 80(1):19-29. PubMed ID: 15794127
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for vertebrate filamin dimerization.
Pudas R; Kiema TR; Butler PJ; Stewart M; Ylänne J
Structure; 2005 Jan; 13(1):111-9. PubMed ID: 15642266
[TBL] [Abstract][Full Text] [Related]
38. The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy.
Löwe T; Kley RA; van der Ven PF; Himmel M; Huebner A; Vorgerd M; Fürst DO
Hum Mol Genet; 2007 Jun; 16(11):1351-8. PubMed ID: 17412757
[TBL] [Abstract][Full Text] [Related]
39. Calpain abolishes the effect of filamin on the actomyosin system in platelets.
Onji T; Takagi M; Shibata N
Biochim Biophys Acta; 1987 Apr; 912(2):283-6. PubMed ID: 3030436
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the mouse mu-calpain gene reveals an essential role in platelet function.
Azam M; Andrabi SS; Sahr KE; Kamath L; Kuliopulos A; Chishti AH
Mol Cell Biol; 2001 Mar; 21(6):2213-20. PubMed ID: 11238954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
